Nitrogen-doped reduced graphene oxide/black phosphorus quantum dot composites for electrocatalytic treatment of choroidal melanoma
Source abstract
Abstract
Choroidal melanoma (CM) is a melanocyte-derived intraocular malignancy that poses a great threat to patients’ vision and life. Electrochemical therapy, which relies on the generation of reactive oxygen species via an oxygen reduction reaction (ORR) to kill target cells, has emerged as a promising approach for the local treatment of malignant tumors. In this study, nitrogen-doped reduced graphene oxide (N-rGO) was electrostatically bound with black phosphorus (BP) quantum dots to form a composite system (N-rGO-BP) for tumor therapy. Owing to the synergistic effect of the two components, the optimal catalyst (N-rGO-BP-12) exhibits improved electrochemical properties and stability, achieving a more positive half-wave potential of 0.66 V and a larger steady-state current density of 2.76 mA cm −2 compared with the N-rGO precursor. In electrochemical therapy, N-rGO-BP-12 undergoes ORR via a two-electron pathway in the acidic microenvironment of the tumor, producing large amounts of hydrogen peroxide and hydroxyl radical to kill tumor cells; only 25 % of the human CM cells survive after 3 h of the treatment. This study provides a new approach for the synthesis and application of electrochemical catalysts for clinical tumor therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanocluster Synthesis and Applications · Carbon and Quantum Dots Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Importance of optical coherence tomography and optical coherence tomography angiography in the imaging and differentiation of choroidal melanoma: a review10.3390/cancers14143354 ↗
2. Update on uveal melanoma: translational research from biology to clinical practice (Review)10.3892/ijo.2020.5140 ↗
3. Uveal melanoma: towards a molecular understanding10.1016/j.preteyeres.2019.100800 ↗
4. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death10.1136/bjo.2008.150292 ↗
5. Treatment of primary intraocular melanoma10.1586/14737140.6.4.493 ↗
6. Incidence of uveal malignant melanoma in the resident population of Rochester and Olmsted County, Minnesota10.1016/0002-9394(79)90296-4 ↗
7. Choroidal melanoma: clinical features, classification, and top 10 pseudomelanomas10.1097/ICU.0000000000000041 ↗
8. Headache or eye pain as the presenting feature of uveal melanoma10.1016/j.ophtha.2013.06.015 ↗
9. Very long-term prognosis of patients with malignant uveal melanoma10.1167/iovs.03-0538 ↗
10. Uveal melanoma10.1038/s41572-020-0170-4 ↗
11. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients10.1016/S0161-6420(02)01181-8 ↗
12. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 1010.1016/S0002-9394(98)00039-7 ↗
13. Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma10.1016/j.prro.2013.08.004 ↗
14. Surgical removal of intraocular tumors: dismissing old wives' tales10.1016/j.ajo.2013.01.028 ↗
15. Epidemiologic aspects of uveal melanoma10.1016/0039-6257(88)90173-7 ↗
16. Laser treatment for choroidal melanoma: current concepts10.1016/j.survophthal.2022.05.002 ↗
17. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control10.1016/j.ophtha.2014.09.029 ↗
18. Targeted therapies in melanoma10.1016/j.ctrv.2006.07.009 ↗
19. Melanoma biology and new targeted therapy10.1038/nature05661 ↗
20. A redox-triggered C-centered free radicals nanogenerator for self-enhanced magnetic resonance imaging and chemodynamic therapy10.1016/j.biomaterials.2020.120457 ↗
21. Tumor-specific expansion of oxidative stress by glutathione depletion and use of a Fenton nanoagent for enhanced chemodynamic therapy10.1021/acsami.9b09323 ↗
22. Redox active double wall carbon nanotubes show intrinsic anti-proliferative effects and modulate autophagy in cancer cells10.1016/j.carbon.2014.07.046 ↗
23. Construction of high drug loading and enzymatic degradable multilayer films for self-defense drug release and long-term biofilm inhibition10.1021/acs.biomac.7b01268 ↗
24. Polymerization and coordination synergistically constructed photothermal agents for macrophages-mediated tumor targeting diagnosis and therapy
25. Two-dimensional transition metal dichalcogenide (TMD) nanosheets10.1039/C5CS90037A ↗
26. Design, synthesis, and characterization of graphene-nanoparticle hybrid materials for bioapplications10.1021/cr500537t ↗
27. 2D nanomaterials for cancer theranostic applications10.1002/adma.201902333 ↗
28. Platinum nanoparticles to enable electrodynamic therapy for effective cancer treatment10.1002/adma.201806803 ↗
29. Metal-free catalysts for oxygen reduction reaction10.1021/cr5003563 ↗
30. Metabolism of immune cells in cancer10.1038/s41568-020-0273-y ↗
31. Nitrogen-doped graphene as efficient metal-free electrocatalyst for oxygen reduction in fuel cells10.1021/nn901850u ↗
32. Hydrothermal synthesis of a new kind of N-doped graphene gel-like hybrid as an enhanced ORR electrocatalyst10.1021/acsami.7b19122 ↗
33. Preparation and enhanced visible-light photocatalytic H2-production activity of CdS-sensitized Pt/TiO2 nanosheets with exposed (001) facets10.1039/c1cp20079h ↗
34. Ultrahigh yield of hydrogen peroxide on graphite felt cathode modified with electrochemically exfoliated graphene10.1039/C7TA01534H ↗
35. Enhanced activation of hydrogen peroxide using nitrogen doped graphene for effective removal of herbicide 2,4-D from water by iron-free electrochemical advanced oxidation10.1016/j.electacta.2018.11.196 ↗
36. Low content Pt nanoparticles anchored on N-doped reduced graphene oxide with high and stable electrocatalytic activity for oxygen reduction reaction
37. Recent advancements in Pt and Pt-free catalysts for oxygen reduction reaction10.1039/C4CS00484A ↗
38. Active sites of nitrogen-doped carbon materials for oxygen reduction reaction clarified using model catalysts10.1126/science.aad0832 ↗
39. Current advances in black phosphorus-based drug delivery systems for cancer therapy
40. Black phosphorus quantum dots encapsulated in anionic waterborne polyurethane nanoparticles for enhancing stability and reactive oxygen species generation for cancer PDT/PTT therapy10.1039/D0TB02101F ↗
41. Manganese ion chelated FeOCl@PB@PDA@BPQDs nanocomposites as a tumor microenvironment-mediated nanoplatform for enhanced tumor imaging and therapy10.1016/j.snb.2019.127491 ↗
42. A targeting black phosphorus nanoparticle based immune cells nano-regulator for photodynamic/photothermal and photo-immunotherapy
43. Cobalt nanoparticles/black phosphorus nanosheets: an efficient catalyst for electrochemical oxygen evolution10.1002/advs.201800575 ↗
44. Ultrathin black phosphorus-on-nitrogen doped graphene for efficient overall water splitting: dual modulation roles of directional interfacial charge transfer10.1021/jacs.9b00154 ↗
45. Azide passivation of black phosphorus nanosheets: covalent functionalization affords ambient stability enhancement10.1002/anie.201813218 ↗
46. Stabilizing black phosphorus nanosheets via edge-selective bonding of sacrificial C60 molecules10.1038/s41467-018-06437-1 ↗
47. Facile one step method realizing scalable production of g-C3N4nanosheets and study of their photocatalytic H2evolution activity10.1039/C4TA04487H ↗
48. Molecule-level g-C3N4 coordinated transition metals as a new class of electrocatalysts for oxygen electrode reactions10.1021/jacs.6b13100 ↗
49. Carbon nanosheets: nitrogen-doped porous carbon nanosheets templated from g-C3 N4 as metal-free electrocatalysts for efficient oxygen reduction reaction (Adv. Mater. 25/2016)10.1002/adma.201670178 ↗
50. Synthesis and oxygen reduction properties of three-dimensional sulfur-doped graphene networks10.1039/c4cc01939c ↗
51. Photothermal-reinforced and glutathione-triggered in Situ cascaded nanocatalytic therapy10.1016/j.jconrel.2020.03.007 ↗
52. Elucidating electrocatalytic oxygen reduction kinetics via intermediates by time-dependent electrochemiluminescence
53. Lithium storage: an air-stable densely packed phosphorene–graphene composite toward advanced lithium storage properties (Adv. Energy Mater. 12/2016)10.1002/aenm.201600453 ↗
54. Interfacial covalent bonds regulated electron-deficient 2D black phosphorus for electrocatalytic oxygen reactions